Dr Borna Nyaoke

Dr Borna Nyaoke joined DNDi in February 2018 and took over the Head of Mycetoma Disease role in January 2023.

Dr Borna is a clinical researcher and public health specialist. She is a medical doctor by profession having graduated with a Bachelor of Medicine and Bachelor of Surgery (MBChB) degree from The University of Nairobi, Kenya. She has completed the Global Clinical Scholars Research Training (GCSRT) Programme at the Harvard Medical School, U.S.A  and has a Master of Public Health degree with a concentration in Health Systems Management from the University of Liverpool, U.K.

At DNDi, Dr Borna managed the first-ever randomized, double-blind clinical trial for a new treatment for mycetoma in Khartoum, Sudan. She also managed the ANTICOV trial in Kenya and Sudan, the largest clinical trial in Africa for people with mild to moderate COVID-19 to test new drug combinations in 13 African countries. She supported studies in anti-microbial resistance (neonatal sepsis and sexually transmitted infections) in Kenya and Uganda carried out by the Global Antibiotic Research & Development Partnership (GARDP), a joint initiative by the World Health Organization (WHO) and DNDi.

Dr Borna has expansive experience in clinical research with previous work in epidemiological and simulated studies and Phase I and II clinical trials in HIV and Ebola vaccines.